Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROPOGAST: Propofol vs Remifentanil for Gastroscopy Sedation
NCT07336628Completed
- Sponsor
- Fatih Sultan Mehmet Training and Research Hospital
- Start
- Feb 2026
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of remifentanil in Procedural sedation (PS) (2 arms), sponsored by Fatih Sultan Mehmet Training and Research Hospital. Primary endpoints: Recovery Time at 2 hours and Incidence of Sedation-Related Complications at 2 hours. Started Feb 2026; status: completed.
02
Drugs
remifentanil
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT07336628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07336628.